Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Iio

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Medical Virology|May 23, 1998
GBV-C/HGV infection in chronic hepatitis C patients: its effect on clinical features and interferon therapyM Oshita, N Hayashi, E Mita, et al.
Journal of Viral Hepatitis|December 22, 1999
Influence of transfusion-transmitted virus infection on the clinical features and response to interferon therapy in Japanese patients with chronic hepatitis CH Hagiwara, N Hayashi, E Mita, et al.
Journal of Gastroenterology and Hepatology|October 12, 2001
Significance of serum soluble Fas antigen level in chronic hepatitis C patients treated with interferon: relationship to the therapeutic responseK Ohkawa, N Hiramatsu, K Mochizuki, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Medical Virology|May 23, 1998
GBV-C/HGV infection in chronic hepatitis C patients: its effect on clinical features and interferon therapyM Oshita, N Hayashi, E Mita, et al.
Journal of Viral Hepatitis|December 22, 1999
Influence of transfusion-transmitted virus infection on the clinical features and response to interferon therapy in Japanese patients with chronic hepatitis CH Hagiwara, N Hayashi, E Mita, et al.
Journal of Gastroenterology and Hepatology|October 12, 2001
Significance of serum soluble Fas antigen level in chronic hepatitis C patients treated with interferon: relationship to the therapeutic responseK Ohkawa, N Hiramatsu, K Mochizuki, et al.
Pageof 2